Please read Dr. Samples’ article in the American Journal of Preventive Medicine titled, “Buprenorphine After Nonfatal Opioid Overdose: Reduced Mortality Risk in Medicare Disability Beneficiaries.”
Drug overdose mortality remains an urgent health concern in the U.S., surpassing 105,000 deaths in 2021, largely attributed to opioids. Opioid-involved overdose deaths are preventable with medication for opioid use disorder (MOUD), which has a well-established association with reduced mortality risk during treatment. Nonfatal opioid-involved overdoses represent critical opportunities to initiate potentially life-saving interventions because these events are strong risk factors for subsequent overdose and death. To read the full article.
Buprenorphine After Nonfatal Opioid Overdose: Reduced Mortality Risk in Medicare Disability Beneficiaries. Hillary Samples, Molly A. Nowels, Arthur R. Williams, Mark Olfson, Stephen Crystal. American Journal of Preventive Medicine. Volume 65, Issue 1, P19-29, July 2023. PMID:36906496 PMCID: PMC10293066 DOI: 10.1016/j.amepre.2023.01.037